Products
Products

Portfolio

Committed to better health for individuals, Takeda Pharmaceuticals North America, Inc. (TPNA) develops and markets innovative pharmaceutical treatments.

In addition to the success of our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need.

Click here for more R&D pipeline information

The following prescription drugs are listed for physicians and healthcare professionals.

Click on the product links for more detailed information.

Brand Name
Click for important safety information		 Generic Name Description Complete Prescribing Information
ACTOS pioglitazone HCl Insulin sensitizer for type 2 diabetes mellitus Prescribing Information
ACTOplus met pioglitazone HCl and metformin HCl Insulin sensitizer Prescribing Information
Duetact pioglitazone HCl and glimepiride Insulin sensitizer Prescribing Information
AMITIZA lubiprostone CLC-2 chloride channel activator Prescribing Information
ROZEREM ramelteon MT1/MT2 receptor agonist Prescribing Information
PREVACID lansoprazole Proton pump inhibitor Prescribing Information

ACTOS®, ACTOplus met®, duetact®, ROZEREM®, and Prevacid® are registered trademarks of Takeda Pharmaceutical Company Limited and are used under license by Takeda Pharmaceuticals North America, Inc.

AMITIZA is a registered trademark of Sucampo Pharmaceuticals, Inc.

Please click here to view Takeda’s authorized wholesalers and distributors.

Page Top